Showing results (31-40 of 180) with videos related to
Sort By:
Pageof 18
Cancer|June 22, 2019
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemiaRoni Shouval, Myriam Labopin, Norbert C Gorin, et al.Cancer Medicine|July 10, 2019
Killer immunoglobulin-like receptor genotypes and chronic myeloid leukemia outcomes after imatinib cessation for treatment-free remissionPierre-Yves Dumas, Emilie Bérard, Claire Bréal, et al.Blood Advances|December 22, 2020
Optimizing selection of double cord blood units for transplantation of adult patients with malignant diseasesGiancarlo Fatobene, Fernanda Volt, Frederico Moreira, et al.Bone Marrow Transplantation|February 2, 2022
Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMTArnon Nagler, Myriam Labopin, Xiao-Jun Huang, et al.American Journal of Hematology|November 21, 2018
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remissionXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.Bulletin Du Cancer|July 6, 2022
[Method and impact of allografts cryopreservation during the Covid-19 pandemic: guidelines from the SFGM-TC]Edouard Forcade, Solenn Bacquet, Caroline Ballot, et al.Bone Marrow Transplantation|November 29, 2020
Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMTAnnalisa Paviglianiti, Myriam Labopin, Didier Blaise, et al.Blood Cancer Journal|March 5, 2020
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemiaAnn-Kristin Schmaelter, Myriam Labopin, Gerard Socié, et al.American Journal of Hematology|March 15, 2018
Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) studyZhuoyan Li, Myriam Labopin, Fabio Ciceri, et al.Bone Marrow Transplantation|February 8, 2024
Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donorAnnalisa Paviglianiti, Maud Ngoya, Marta Peña, et al.Pageof 18